Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

NovaBay Pharmaceuticals (NBY) Short-Term Debt repayments (2019 - 2022)

Historic Short-Term Debt repayments for NovaBay Pharmaceuticals (NBY) over the last 5 years, with Q1 2022 value amounting to $105000.0.

  • NovaBay Pharmaceuticals' Short-Term Debt repayments changed N/A to $105000.0 in Q1 2022 from the same period last year, while for Sep 2022 it was $105000.0, marking a year-over-year change of. This contributed to the annual value of $1.0 million for FY2019, which is N/A changed from last year.
  • As of Q1 2022, NovaBay Pharmaceuticals' Short-Term Debt repayments stood at $105000.0.
  • In the past 5 years, NovaBay Pharmaceuticals' Short-Term Debt repayments ranged from a high of $1.0 million in Q1 2019 and a low of $105000.0 during Q1 2022